PhRMA Weighs In On European Consumer Drug Information Proposal
Executive Summary
Supporting a proposed European policy change permitting manufacturers to provide more drug information to the public, the Pharmaceutical Research and Manufacturers of America suggests that permissible information could include ongoing clinical research and disease management data not contained in approved product summaries